Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kashuangping (Pioglitazone/Metformin) as add-on to Sulfonylureas in Type 2 Diabetes
NCT02099838Phase 4Completed
- Sponsor
- Huazhong University of Science and Technology
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin + pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Huazhong University of Science and Technology. Started Jan 2012; status: completed.
02
Drugs
metformin + pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02099838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099838.